Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women.
Author | |
---|---|
Abstract |
:
The combination of genistein 27 mg, cholecalciferol 200 IU, citrated zinc bisglycinate (4 mg elemental zinc) 20 mg per capsule in Fosteum(®), a prescription medical food regulated by the FDA and indicated for the dietary management of osteopenia and osteoporosis, was tested for drug interactions and to determine the pharmacokinetic profile for genistein, the principal bone-modulating ingredient in the product. |
Year of Publication |
:
0
|
Journal |
:
International journal of women's health
|
Volume |
:
3
|
Number of Pages |
:
139-50
|
Date Published |
:
2011
|
URL |
:
http://dx.doi.org/10.2147/IJWH.S19309
|
DOI |
:
10.2147/IJWH.S19309
|
Short Title |
:
Int J Womens Health
|
Download citation |